Venture Capital Pulse — June 3, 2026
Global venture funding reached $92 billion in May 2026, with Anthropic's $50 billion mega-round dominating the month's activity. Defense tech startups hit an all-time record, while non-AI sectors like robotics, orbital logistics, and healthcare automation emerged as unexpected winners competing for capital outside the AI-dominated funding landscape.
Venture Capital Pulse — June 3, 2026
Top Deals This Week
Mecka AI — $60 million Series A
- Sector: Robotics / AI Data Training
- Lead investor(s): Framework Ventures (crypto VC)
- What they do: Trains robots using human body sensor data and smartphone inputs
- Why it matters: Represents a shift toward robotics automation backed by crypto VCs; company projects $100M annual run rate, signaling investor confidence in embodied AI as differentiation from pure software AI plays
- Valuation: Not disclosed
Modal Labs — $355 million (May 2026)
- Sector: AI Infrastructure / Compute
- Lead investor(s): Not disclosed in available data
- What they do: AI compute platform for the next wave of machine learning workloads
- Why it matters: One of 11 largest NYC funding rounds in May 2026, representing continued demand for AI infrastructure that powers training and inference at scale
NewLimit — $435 million
- Sector: Biotech / Longevity
- Lead investor(s): Not disclosed
- What they do: Clinical-stage biotechnology focused on age-related disease
- Why it matters: Part of broader biotech funding rebound; signals renewed investor appetite for capital-intensive life sciences outside pure AI
Accro — $50 million Series C
- Sector: Biotech
- Lead investor(s): Not disclosed
- What they do: Biotech development platform
- Why it matters: Demonstrates consistent Series C funding appetite in biopharma, even amid AI capital concentration
Sector Spotlight
Defense Tech Shatters All-Time Records
Defense, national security, and law enforcement startups have attracted $14.6 billion in venture investment through mid-2026, already surpassing the entire 2025 annual record of $9.6 billion. This explosive growth signals a fundamental repricing of geopolitical risk in venture capital allocation.
Key drivers include AI-powered autonomous systems, drone manufacturing, satellite-based ISR (intelligence, surveillance, reconnaissance), and precision manufacturing for defense supply chains. Companies like Anduril remain central to this trend, but the breadth of capital flowing into the sector has widened dramatically—orbital logistics, composite manufacturing, and even specialized defense robotics are now attracting mega-rounds from tier-1 VCs.
The sector's momentum contrasts sharply with the AI mega-round dominance: while Anthropic and other AI labs consumed 54% of May's $92B in global funding, defense tech is emerging as the second-most capitalized vertical, attracting investors seeking differentiation and geopolitical hedges outside the crowded LLM and inference infrastructure markets.
Sector Diversification Beyond AI
In the past 48 hours, the largest VC checks went to orbital logistics, male contraception, fleet electrification, composite supply chains, and clinically anchored healthcare automation—none of which are pure-play AI startups. This signals founder and investor fatigue with software-only AI plays and renewed appetite for capital-intensive, hard-tech sectors where AI acts as an enabler rather than the core product.
Exits & Acquisitions
No recent IPO or major M&A announcements were confirmed in the past 7 days. However, the exit market is expected to reopen imminently following the May funding boom—Crunchbase reports that "the exit market reopened" as a secondary signal of May's capital influx rippling through fund deployments.
What to Watch Next Week
- IPO filing season: Multiple venture-backed companies expected to file S-1s in June, riding momentum from May's record funding
- Defense tech mega-rounds: Watch for additional Series B/C closings in orbital, autonomous systems, and precision manufacturing startups
- LP commitment announcements: Family offices and limited partners expected to announce new fund commitments in response to demonstrated returns from 2021–2023 vintage AI funds
- Biotech sector momentum: NewLimit and Accro's large rounds suggest Series B/C velocity in longevity and clinical biotech could accelerate through Q2
Data & Sources:
- Global May funding: $92B (Crunchbase)
- Defense tech record: $14.6B YTD 2026 vs. $9.6B full-year 2025
- NYC funding: $1.3B across 11 largest May rounds
This content was collected, curated, and summarized entirely by AI — including how and what to gather. It may contain inaccuracies. Crew does not guarantee the accuracy of any information presented here. Always verify facts on your own before acting on them. Crew assumes no legal liability for any consequences arising from reliance on this content.
Powered by
